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Charles B Holmes, Lawrence O Gostin

Introduction
Coronavirus disease 2019 (COVID-19) has revealed how
strikingly unprepared the world is for a pandemic and
how easily viruses spread in our interconnected world.
A governance crisis is unfolding alongside the pandemic
as health officials around the world compete for access to
scarce medical supplies. As governments of African
countries, and those in low-income and middle-income
countries around the world, seek to avoid potentially
catastrophic epidemics and learn from what has worked
in other countries, testing and other medical resources
are of concern. With accelerating spread, funding is
urgently needed. Yet even where there is enough money,
many African health authorities are unable to obtain the
supplies needed as geopolitically powerful countries
mobilise economic, political, and strategic power to
procure stocks for their populations.1,2
We have seen this before. In the AIDS pandemic
lifesaving diagnostics and drugs came to many African
countries long after they were available in Europe and
North America. In 2020, this situation can be avoided.
Although health system weakness remain acute in
many places, investments by national governments, the
African Union, and international initiatives to tackle
AIDS, tuberculosis, malaria, polio, and post-Ebola
global health security have built important public health
capacities. Global leaders have an ethical obligation to
avoid needless loss of life due to the foreseeable prospect
of slow and inadequate access to supplies in Africa.

COVID-19 testing and response strategies
Having navigated Ebola, HIV, and tuberculosis epidemics,
and a range of annual, sporadic, and concurrent outbreaks,
several African countries have unparalleled disease
response capacity. African governments are offering rare
examples of effective international cooperation on
COVID-19. The African Union started early to strengthen
response with readiness assessments, an emergency
ministerial meeting, and a continental strategy. However,
with a highly transmissible and fast spreading virus these
strengths can quickly be overwhelmed.
In the absence of a vaccine or highly-effective
treatment, widespread testing is crucial to halting
transmission and death, especially with presymptomatic
transmission responsible for up to 44% of secondary
infections.3 For example, South Africa, South Korea, and
Germany are reporting tentative signs of success through
mass testing, isolation, contact tracing, and physical
distancing. Extensive testing efforts have been key to
some of the lowest fatality rates in the world.4 South
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Africa, which has the second largest economy in Africa,
put community testing at the core of its multifaceted
response. Although testing 2·7 per thousand members
of the population is lower than Germany and South Korea,
the strategy in South Africa—with over 4000 reported
cases and 79 deaths as of April 25, 2020—is yielding
similar fatality rates.5 With only 2·8% of those tested
being positive for COVID-19, there is hope for rapidly
scaling testing to detect and halt community spread.5
COVID-19 cases have been reported across the African
continent—with the number of confirmed cases passing
30 000 on April 25, 2020.5 These numbers reflect
restricted testing as higher capacity countries, such as
South Africa, Morocco, and Algeria, report many times
more cases than countries with lower testing capacity
(eg, Nigeria). The African CDC has announced a plan for
1 million tests and a promising partnership aiming to
produce 10 million tests, but this will not solve the
immediate need.6
National contexts and responses are diverse—which
will continue in the short-term and longer-term. African
governments are applying an assortment of nonpharmaceutical interventions including quarantines,
curfews, closures of markets and schools, and restrictions
on the types and number of attendees at social gatherings,
with successes and challenges. Rwanda, a country of
12 million people with a universal health care structure,
implemented a lockdown shortly after the first detected
case of COVID-19 (reported on March 8, 2020) and the
government is supplying 20 000 households with free
food through a social protection scheme. Ethiopia, one of
Africa’s largest countries of over 100 million people,
declared a state of emergency, postponed highly antici
pated elections, and closed borders, but has not
implemented a lockdown movement in the country.
In many high population density, unplanned areas of
Africa’s megacities, distancing is not feasible. Where
informal employment is common, the social and
economic consequences of shutdowns will be severe.
Many people face food insecurity and economic crises
amidst lockdowns. Targeted interventions, informed by
testing, are needed to allow day-wage workers to work
and children who are at a higher-risk of the disease to
return to school.
Testing strategies are key to ameliorating economic
and social hardship, concentrating resources, and
allowing more targeted interventions. For example,
South Korea has been able to avoid the kind of full-scale
lockdowns required elsewhere. In South Africa, testing
data has informed a five-tier risk adjusted strategy to

Published Online
May 7, 2020
https://doi.org/10.1016/
PII
Department of International
Health (M M Kavanagh PhD),
O’Neill Institute for National
and Global Health Law
(M M Kavanagh,
Prof L O Gostin JD), School of
Medicine, Georgetown
University, Washington DC,
USA (C B Holmes MD); Centre
for Universal Health, Chatham
House, London, UK
(N A Erondu PhD); Redeemer’s
University, Ede, Nigeria
(Prof O Tomori PhD);
US National Academy of
Medicine, Washignton DC, USA
(V J Dzau MD); KEMRI-Wellcome
Trust Research Programme,
Narobi, Kenya (E A Okiro PhD);
Kenya Legal and Ethical Issues
Network on HIV and AIDS,
Narobi, Kenya (A Maleche LLB);
Health Strategy and Delivery
Foundation, Abuja, Nigeria
(I C Aniebo PhD); TH Chan
School of Public Health,
Harvard University, Boston,
MA, USA (I C Aniebo); and
Section 27, Johannesburg,
South Africa (U Rugege MA)
Correspondence to:
Dr Matthew Kavanagh,
Department of International
Health, Georgetown University,
Washington DC 20057, USA
matthew.kavanagh@
georgetown.edu

1

20TL7673
Viewpoint

For more on Africa CDC see
https://africacdc.org/covid-19/
For more on PEPFAR Panorama
see https://data.pepfar.gov/
dashboards

2

ease lockdown measures based on incidence and 1 infection control, and community networks are ready to
readiness.
be harnessed. By March 7, 2020, laboratories in 43 African
Meanwhile, China’s 3·6 critical care beds per countries could already do COVID-19 testing.12 Africa
100 000 population was insufficient during the COVID-19 leads much of the world in community health-care
epidemic.7 Malawi has as few as 25 critical care beds for 5 networks that could be mobilised for the hard work of
19 million people—or 0·1 beds per 100 000 people,8 and communication, testing, and contact tracing.13
most counties in Kenya reportedly have no functioning
However, restricted supplies of test reagents and
ventilators.9 Although a lower median age might help, consumables is making it difficult to mobilise capacity.
the number of people with malnutrition, HIV, and The manufacturers of PCR platforms, such as Roche,
tuberculosis in the region could increase the need for 10 Abbott, Hologic, Thermo Fisher, and Cepheid) cannot
critical care. In Veneto, Italy home-based care was scale up production quickly enough. A WHO-validated
combined with widespread testing and early diagnosis, rapid diagnostic test could provide a faster and cheaper
resulting in a mortality rate four-times lower than that alternative to PCR.14 Currently, only a few rapid immuno
reported in Lombardy.10 Such home-based care could be a diagnostic tests with high specificity and sensitivity are
model for African contexts, building on community-level 15 available and only in higher-income settings.
response experiences from the West African Ebola
Countries in Africa have worked to procure swabs,
outbreak.11
reagents, test cartridges, and other commodities using
national and donor funds. This is a complex endeavor
Africa competes for testing kits and a future
with bottlenecks in procuring multiple laboratory
vaccine
20 consumables, specific to the platforms in a given
Rolling out testing, tracing, and care across Africa will not geography. Despite best efforts, procurement remains a
be easy. Increased funding from national governments problem. One of the biggest deliveries has been tens of
and donors is urgently needed. But recent investments thousands of tests to each African Union member state
have created important capacities. Africa CDC is providing from the Jack Ma Foundation, but additional components
strong coordination and COVID-19 guidance; additionally, 25 need to be procured.15 Africa CDC has a plan to distribute
strengthened national public health institutes, referral 1 million tests,6 but even with a newly established pooled
laboratories, laboratory and epidemiology workforce, purchasing platform that secured 100 000 tests from
Germany, in April, 2020, the continent falls very short
from the tens of millions tests the UN estimates will be
Tests to
Reported HIV tests
HIV viral load
reach 1%
COVID-19 done (Oct 1– tests done
30 required.16 Health officials report procurements have
of the
tests
Dec 31, 2019) (Oct 1, 2018–
been unsuccessful because supplies have already been
population done*
Sept 30, 2019)
purchased for use in North America and Europe.17,18
South Africa
593 087 161 004
7 287 515
2 730 530
There are several factors slowing testing—from demand
Kenya
537 713
16 738
2 177 170
1 046 910
to insufficient staff and specimen referral systems.
Uganda
457 410
20 329
2 098 734
1 012 685
35 However, the need for diagnostics has never been higher.
Mozambique
312 554
1 644
1 814 959
583 689
Many countries with successful testing strategies
Tanzania
597 342
652
1 462 879
913 255
have rapidly reached at least 1% of their population. By
Nigeria
2 061 396
10 061
1 160 920
576 469
early April, South Korea had tested 1% of its entire
Malawi
191 300
617
1 060 031
539 532
population while Germany surpassed 1·5%, now testing
Zambia
183 840
5 341
948 247
643 163
40 over 500 000 people each week.19 The table shows the
Zimbabwe
148 629
6 067
645 402
487 182
numbers of tests needed to reach this level in African
Côte d’Ivoire
263 783
1 545
495 543
200 337
countries for which data is complete, compared with the
DR Congo
895 614
1 425
203 859
72 549
low reported numbers of COVID tests done. Yet, with the
Cameroon
265 459
6 352
197 965
89 113
expansion of funding and supplies, widespread testing is
Rwanda
129 522
18 556
187 915
85 657
45 possible (eg, using trained staff and platforms from the
AIDS and tuberculosis response). The table also shows
Ethiopia
1 149 636
13 645
136 307
332 528
over half of countries did more HIV tests between
South Sudan
111 937
91
79 992
13 284
Oct 1, 2019 and Dec 31, 2019 than the 1% target for
Burundi
118 908
204
61 074
33 772
COVID-19 testing; capacity for more complex HIV viral
Botswana
23 516
4 432
36 219
145 776
50 load testing last year approached this level.
Ghana
310 729
68 591
25 426
13 733
On vaccines and therapies, the current situation of
Overall
8 352 375
337 294
20 080 157
9 520 164
inequitable access will repeat without action, as leaders
Only countries for which there is full data available are included. Data obtained
highlighted at the launch of a new international effort to
from Africa CDC and PEPFAR Panorama.COVID-19=coronavirus disease 2019.
accelerate COVID-19 tools.20 Rich countries monopolising
*Test done up until April 26, 2020.
55 vaccine markets would mirror past actions.21 Meanwhile,
Table: COVID-19 testing needs and HIV testing in selected countries in
demand for masks, gloves, and other personal protective
sub-Saharan Africa
equipment face similar dynamics.
www.thelancet.com Published online May 7, 2020 https://doi.org/10.1016/PII

20TL7673
Viewpoint

Ethics and human rights in pandemics

1 must not ignore the effects of market forces and their
The ethical frameworks for allocating scarce resources procurements on other countries.
largely apply within, not between, countries.22 WHO
Short-term and medium-term actions are needed. The
instruments like the International Health Regulations African Union’s Partnership to Accelerate COVID-19
and Pandemic Influenza Framework are inapplicable. 5 Testing (PACT) is an important step. WHO has been
Binding human rights treaties are not specific on providing critical support through guidelines, convening,
distributing scarce goods in health emergencies.23 World and coordinated programmes. Pooling regional procur
Trade Organization rules require free flow of medical ement is needed, which can be improved through
goods in the market, with little provision for crises when cooperation between Africa CDC and the WHO-led UN
markets inequitably distribute goods in ways that 10 Supply Chain Taskforce, the Global Fund to Fight AIDS,
undermine public health.
Tuberculosis, and Malaria, and other organisations.
The AIDS pandemic should have taught us this lesson. Mechanisms for equitable distribution might require
Scale up of HIV diagnosis and treatment in African decisions based on population size and risk, prioritising
public health systems arrived years after North America health workers, and allowing countries to draw down
and Europe, long after the pandemic had taken hold.24 In 15 allocations of supplies as needed without fear of losing
HIV, market forces impeded access through insufficient access. African governments must mobilize domestic
financing, high prices, and intellectual property barriers. funds, while bilateral and multilateral aid must be
In COVID-19, market forces are different—adding increased—with resources flowing in weeks, not months.
unequal procurement power. Yet the results will be the External funding streams could be channeled through
same without action.
20 existing mechanisms like the Global Fund, which opened
Governments have an obligation to protect their own a new mechanism to receive and distribute funds for
citizens. However, principles of fairness must be applied. COVID-19 in April 9, 2020. Securing open access to
No single community, country, or continent should bear newly developed products and fair pricing will require
the full brunt of global shortages. Although difficult coordinated action by WHO and national governments.
decisions in resource allocation are inevitable, it is 25 Serious efforts to overcome barriers to regional
unethical for African countries to have considerably less production and reduce reliance on foreign equipment are
access and harder choices than others.
overdue—for diagnostics, personal protective equipment,
and with sufficient investment for both vaccines and
Toward coordinated effort for ethical access
therapies. South Africa, Kenya, Zimbabwe, and Morocco
Political leadership is urgently required to secure ethical 30 have begun either scaling up existing production or
global allocation of scarce resources. It is entirely converting universities and non-health industries to
foreseeable that many countries will be locked out of the improve access to personal protective equipment. A
market. Governments have structured the global trading partnership, led by Institut Pasteur, Dakar, Senegal, is
system and they have the power now to ameliorate its ill advancing a prototype affordable, rapid test that could be
effects during a crisis. This is an ethical imperative but 35 produced in the millions.26 Past lessons show that national
also a shared interest; the COVID-19 pandemic has governments can incentivise production, but international
taught us that unaddressed outbreaks in one part of the cooperation has been shown to be criucial for ensuring
world put people throughout the world at risk.
financing and technology transfer—with collaboration
Political convening is urgent, yet many international between governments and manufacturers in low-income
forums are struggling without consensus from powerful 40 and middle-income countries particularly powerful.27
states. It will be hard to convince some governments to
do anything besides maximising access for their own Conclusion
citizens. A new COVID-19 accelerator on vaccines, Every life has equal worth. Yet global allocation of testing
diagnostics, and treatments could offer a promising and other goods currently means that some are forced to
venue in a moment where international cooperation is at 45 wait, while those ahead in the global procurement line take
a low point. With leadership from the extended G20 and precedence. In 2020, we have the opportunity to learn
EU, coordinated by WHO, it engages a range of financing from past mistakes by countering market forces, thus
agencies including the Gates Foundation, World Bank, ensuring that lives on the African continent count equally.
Global Fund, Global Alliance for Vaccines and Doing so will take both moral clarity and political courage.
Immunization, and Wellcome Trust. To be effective, the 50 Contributors
effort must be transparent, bold, collaborative, and All authors conceived of the Viewpoint together. MMK, NAE, and ICA
explicitly address thorny ethnical issues in affordability, drafted initial text, EAO searched media reports, and OT and MMK
compiled the table. The text was revised and edited significantly by all
access, and distribution for the global public good. It authors.
needs to include strong African leadership and must be
Declaration of interests
conscious of the “asymmetrical power structures that 55 VJD reports deferred compensation from Medtronic Inc until 2018 for
still dominate the largely high-income-country concept services on the Board of Directors which ended in 2014. All other
of global health.”25 Governments in advanced economies authors report no competing interests.
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